Djokovic et al. found that APS subjects who experienced cerebrovascular thrombotic complications were more likely to be diagnosed with IgG β2GP1 antibodies than those who had not experienced these complications [18]. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.